Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.

Ratios (Summary)
Net Fixed Asset Turnover
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)
Total Asset Turnover
Equity Turnover

Allergan PLC, long-term (investment) activity ratios (quarterly data)

		Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014
	Net fixed asset turnover
	Net fixed asset turnover (including operating lease, right-of-use asset)
	Total asset turnover
	Equity turnover

Ratio	Description	The company
Net fixed asset turnover	An activity ratio calculated as total revenue divided by net fixed assets.	Allergan PLC’s net fixed asset turnover deteriorated from Q3 2018 to Q4 2018 and from Q4 2018 to Q1 2019.
Net fixed asset turnover (including operating lease, right-of-use asset)	An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset).	Allergan PLC’s net fixed asset turnover (including operating lease, right-of-use asset) deteriorated from Q3 2018 to Q4 2018 and from Q4 2018 to Q1 2019.
Total asset turnover	An activity ratio calculated as total revenue divided by total assets.	Allergan PLC’s total asset turnover improved from Q3 2018 to Q4 2018 and from Q4 2018 to Q1 2019.
Equity turnover	An activity ratio calculated as total revenue divided by shareholders’ equity.	Allergan PLC’s equity turnover improved from Q3 2018 to Q4 2018 and from Q4 2018 to Q1 2019.

Allergan PLC, net fixed asset turnover calculation (quarterly data)

		Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014
	Selected Financial Data (USD $ in thousands)
	Net revenues
	Property, plant and equipment, net
	Ratio
	Net fixed asset turnover¹

Q1 2019 Calculations

¹ Net fixed asset turnover = (Net revenues_{Q1 2019} + Net revenues_{Q4 2018} + Net revenues_{Q3 2018} + Net revenues_{Q2 2018}) ÷ Property, plant and equipment, net
= ( hidden + hidden + hidden + hidden ) ÷ hidden = hidden

Ratio	Description	The company
Net fixed asset turnover	An activity ratio calculated as total revenue divided by net fixed assets.	Allergan PLC’s net fixed asset turnover deteriorated from Q3 2018 to Q4 2018 and from Q4 2018 to Q1 2019.

Allergan PLC, net fixed asset turnover (including operating lease, right-of-use asset) calculation (quarterly data)

		Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014
	Selected Financial Data (USD $ in thousands)
	Net revenues

	Property, plant and equipment, net
	Right of use asset, operating leases
	Property, plant and equipment, net (including operating lease, right-of-use asset)
	Ratio
	Net fixed asset turnover (including operating lease, right-of-use asset)¹

Q1 2019 Calculations

¹ Net fixed asset turnover (including operating lease, right-of-use asset) = (Net revenues_{Q1 2019} + Net revenues_{Q4 2018} + Net revenues_{Q3 2018} + Net revenues_{Q2 2018}) ÷ Property, plant and equipment, net (including operating lease, right-of-use asset)
= ( hidden + hidden + hidden + hidden ) ÷ hidden = hidden

Ratio	Description	The company
Net fixed asset turnover (including operating lease, right-of-use asset)	An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset).	Allergan PLC’s net fixed asset turnover (including operating lease, right-of-use asset) deteriorated from Q3 2018 to Q4 2018 and from Q4 2018 to Q1 2019.

Allergan PLC, total asset turnover calculation (quarterly data)

		Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014
	Selected Financial Data (USD $ in thousands)
	Net revenues
	Total assets
	Ratio
	Total asset turnover¹

Q1 2019 Calculations

¹ Total asset turnover = (Net revenues_{Q1 2019} + Net revenues_{Q4 2018} + Net revenues_{Q3 2018} + Net revenues_{Q2 2018}) ÷ Total assets
= ( hidden + hidden + hidden + hidden ) ÷ hidden = hidden

Ratio	Description	The company
Total asset turnover	An activity ratio calculated as total revenue divided by total assets.	Allergan PLC’s total asset turnover improved from Q3 2018 to Q4 2018 and from Q4 2018 to Q1 2019.

Allergan PLC, equity turnover calculation (quarterly data)

		Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014
	Selected Financial Data (USD $ in thousands)
	Net revenues
	Shareholders’ equity
	Ratio
	Equity turnover¹

Q1 2019 Calculations

¹ Equity turnover = (Net revenues_{Q1 2019} + Net revenues_{Q4 2018} + Net revenues_{Q3 2018} + Net revenues_{Q2 2018}) ÷ Shareholders’ equity
= ( hidden + hidden + hidden + hidden ) ÷ hidden = hidden

Ratio	Description	The company
Equity turnover	An activity ratio calculated as total revenue divided by shareholders’ equity.	Allergan PLC’s equity turnover improved from Q3 2018 to Q4 2018 and from Q4 2018 to Q1 2019.

	Allergan PLC	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

Allergan PLC (AGN)

Long-term (Investment) Activity Analysis
Quarterly Data

Ratios (Summary)

Net Fixed Asset Turnover

Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)

Total Asset Turnover

Equity Turnover

Allergan PLC (AGN)

Long-term (Investment) Activity AnalysisQuarterly Data

Ratios (Summary)

Net Fixed Asset Turnover

Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)

Total Asset Turnover

Equity Turnover

Long-term (Investment) Activity Analysis
Quarterly Data